Dithranol; 1,8-Dihydroxyanthrone; 1,8-Dihydroxy-9-anthrone; 1,8-Dihydroxyanthracen-9(10H)-one; Chrysodermol; Cignolin; 9(10H)-Anthracenone, 1,8-dihydroxy-; Cigthranol; 1,8-dihydroxy-10H-anthracen-9-one; Batridol; Psoriacid-Stift; Anthra-Derm; Anthrone, 1,8-dihydroxy-; Drithoscalp; DrithoCreme; 1,8-DIHYDROXY-9(10H)-ANTHRACENONE; NSC 43970; Anthraline; NSC 629313; UNII-U8CJK0JH5M; Anthralin [USP]; Anthralin (Dithranol); MFCD00053409; U8CJK0JH5M; CHEMBL46469; Anthralin (USP); Dithranol (INN); Dithranol [INN]; NSC-43970; NSC629313; NSC-629313; NCGC00091330-01; DSSTox_CID_4538; 1,8-Dihydroxy-9(10H)-anthracenone;Anthralin; DSSTox_RID_77448; DSSTox_GSID_24538; Dithranolum; 1,8,9-Trihydroxyanthracene, 97%; Dithranolum [INN-Latin]; Zithranol-RR; CCRIS 628; SR-05000002011; EINECS 214-538-0; BRN 2054360; Psodadrate; Prestwick_528; Anthralin, Dithranol; Dithranol ,(S); Anthrone,8-dihydroxy-; Spectrum_000056; ANTHRADERM (TN); Spectrum2_000111; Spectrum3_000304; Spectrum4_000151; Spectrum5_000820; Epitope ID:114081; 1,8-dihydroxy-9-anthrane; cid_2202; SCHEMBL3197; BSPBio_001868; KBioGR_000622; KBioSS_000436; 4-06-00-07602 (Beilstein Handbook Reference); MLS001332632; MLS002415712; DivK1c_000021; SPECTRUM1500127; SPBio_000122; ZINC1322; Dithranol, >=90% (HPLC); DTXSID7024538; CTK8A0163; HMS500B03; KBio1_000021; KBio2_000436; KBio2_003004; KBio2_005572; KBio3_001368; NUZWLKWWNNJHPT-UHFFFAOYSA-; NINDS_000021; HMS1920E07; HMS2091K07; HMS2271B09; HMS3715H19; Pharmakon1600-01500127; HY-B0738; NSC43970; 9(10H)-Anthracenone,8-dihydroxy-; Tox21_111115; Tox21_201851; Tox21_300290; BDBM50041802; CCG-38920; NSC755873; s4590; 1,8-dihydroxy-9-(10H)anthracenone; AKOS015914122; Tox21_111115_1; 9(10H)-Anthracenone,1,8-dihydroxy-; DB11157; KS-5183; MCULE-8492759735; NSC-755873; 1,8-dihydroxy-10-hydroanthracen-9-one; IDI1_000021; 1,8-Dihydroxy-9(10H)-anthracenone #; NCGC00091330-02; NCGC00091330-03; NCGC00091330-04; NCGC00091330-05; NCGC00091330-07; NCGC00253941-01; NCGC00259400-01; AC-14842; NCI60_004019; SC-19051; SBI-0051286.P003; AB0105711; DB-060606; 1,8-dihydroxy-9,10-dihydroanthracen-9-one; FT-0625372; ST50825759; C06831; D00233; K-1044; 9(10H)-Anthracenone, 1,8-dihydroxy- (9CI); AB00051916_07; Q419397; SR-05000002011-1; SR-05000002011-2; W-108602